Circular RNAs and their roles in idiopathic pulmonary fibrosis

Respir Res. 2024 Feb 6;25(1):77. doi: 10.1186/s12931-024-02716-2.

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease with limited treatment options. Circular RNAs (circRNAs) have emerged as a novel class of non-coding RNAs with diverse functions in cellular processes. This review paper aims to explore the potential involvement of circRNAs in the pathogenesis of IPF and their diagnostic and therapeutic implications. We begin by providing an overview of the epidemiology and risk factors associated with IPF, followed by a discussion of the pathophysiology underlying this complex disease. Subsequently, we delve into the history, types, biogenesis, and functions of circRNAs and then emphasize their regulatory roles in the pathogenesis of IPF. Furthermore, we examine the current methodologies for detecting circRNAs and explore their diagnostic applications in IPF. Finally, we discuss the potential utility of circRNAs in the treatment of IPF. In conclusion, circRNAs hold great promise as novel biomarkers and therapeutic targets in the management of IPF.

Keywords: Alveolar epithelium; Circular RNA; Fibroblasts; Idiopathic pulmonary fibrosis.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Humans
  • Idiopathic Pulmonary Fibrosis* / drug therapy
  • RNA, Circular*

Substances

  • RNA, Circular
  • Biomarkers